Ido Zairi
Co-Founder and Managing Partner @ Israel Biotech Fund
New York, United States
Ido Zairi is a venture - series unknown investor at Israel Biotech Fund in New York focused on Health Care and Therapeutics. Ido Zairi is based out of Rehovot, HaMerkaz and is the Co-Founder and General Partner of Israel Biotech Fund and Managing Director of Mendham Investment Group. Ido previously worked at Jefferies as a Managing Director, Head of Risk Management. Ido Zairi attended the Hebrew University of Jerusalem.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Ido Zairi invests in
Stages Ido Zairi invests in
Countries Ido Zairi invests in
Investment Focus
Industry
- Health Care 1 (100%)
- Therapeutics 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Vensica Medical
|
Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates. | $16M / Venture - Series Unknown / Nov 01, 2021 |
Co-Investors
About Israel Biotech Fund
Israel Biotech Fund – Building the future of Israeli BiotechIsrael Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies.Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages.Ourpartners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals.Our key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support.We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance.We provide our portfolio companies with the necessary resources for long-term sustainable growth. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Israel’s Biotech industry which increases investment opportunities.The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.
Israel Biotech Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ido Zairi
Co-Founder and Managing Partner
|
|||
Yuval Cabilly
Co-Founder and General Partner
|
|||
David Sidransky
Co-Founder and General Partner
|
|||
Jeffrey B. Kindler
Fund Advisor
|
|||
Jonathan Fassberg
Fund Advisor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ido Zairi invest in?
Ido Zairi invests primarily in Health Care, Therapeutics and Medical Device startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ido Zairi last invest?
The most recent investment recorded for Ido Zairi closed in Nov 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
